GlassScriptPhysician profile
Berlinda Pickens
NPI 1497334973
$2,626.92
in general payments reported to CMS, 2019-2025
12 companies · $1,750 in 2025
The $1,750 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.07 · 2022: $354 · 2023: $347 · 2024: $161 · 2025: $1,750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,235 · Food and Beverage: $1,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,234.94 |
| Food and Beverage | $1,023.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,391.66 | 2025 | |
| Stryker Corporation | $669.30 | 2022-2024 | Salvation, Prophecy, Prostep |
| Aroa Biosurgery Incorporated | $139.09 | 2025 | |
| Trice Medical, INC. | $75.54 | 2025 | |
| Smith+Nephew, INC. | $74.35 | 2022-2024 | Collagenase Santyl |
| Kci USA, INC. | $61.67 | 2022-2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Ibsa Pharma INC. | $60.70 | 2025 | Flector, Licart, Tirosint |
| Tactile Systems Technology INC | $57.82 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Sebela Pharmaceuticals INC. | $31.17 | 2021-2022 | |
| Reprise Biomedical, INC. | $24.05 | 2025 | Miro3d |
| Ets Wound Care LLC | $21.39 | 2023 | |
| Access Pro Medical, LLC | $20.18 | 2025 | Matriderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Berlinda Pickens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.